Additionally, Medtronic's AiBLE™ spine surgery ecosystem and connected insulin delivery platforms further signal its growing focus on AI-integrated healthcare solutions.

Additionally, Medtronic's AiBLE™ spine surgery ecosystem and connected insulin delivery platforms further signal its growing focus on AI-integrated healthcare solutions.

Medtronic does not undertake to update its forward-looking statements or any of the information contained in this press release, including to reflect future events or circumstances.

GALWAY, Ireland, May 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 ...

An Ohio music conductor battling Parkinson's has found relief with adaptive deep brain stimulation, nearly eliminating tremors that threatened his career.

The United States Food and Drug Administration (FDA) recently approved the Medtronic Adaptive Deep Brain Stimulation (aDBS) system for use in the U.S. for patients with Parkinson’s disease.

To apply the latest technology to Schena’s treatment, a representative for Medtronic, the company that makes the aDBS system, was present in a lunchroom crowded with doctors, research fellows ...

The May 2025 issue of Medical Design & Outsourcing features next-gen inhalable vaccine delivery, type 2 diabetes tech and Medtronic aDBS.

Last week, Krehbiel became the first person in the US to receive adaptive Deep Brain Stimulation (aDBS), a newly FDA-approved treatment for symptoms of Parkinson’s disease. — Bay Area News ...

Dr. Helen Bronte-Stewart shows a Medtronic neurostimulator, the device implant that delivers adaptive Deep Brain Stimulation (aDBS) with electrical signals that adapt in response to the Parkinson ...